Abstract
Recent data suggest that statins block HIV-1 replication, which may have important implications for an alternative treatment for AIDS. We tested different statins in cell culture against HIV and conducted a pilot study in HIV-positive patients receiving simvastatin. No anti-HIV activity was detected at subtoxic concentrations and simvastatin did not induce a significant change in the mean viral load or CD4 cell count in study patients. We caution on the use of statins as antiretroviral agents.
Original language | English |
---|---|
Pages (from-to) | 1697-1700 |
Journal | AIDS |
Volume | 19 |
Issue number | 15 |
DOIs | |
Publication status | Published - 14 Oct 2005 |